← Leaderboards
Ichiro Nakano
University Of California Los Angeles
$7,010,147
Attributed
$10,614,246
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2009–22$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$10,614,246 · 9
By mechanism
R01$9,164,873 · 6
R21$747,650 · 2
P01$701,723 · 1
Top collaborators
- Richard A. Cerione8 shared
- Jeongwu Lee6 shared
- Jeremy N Rich6 shared
- Luiz Otavio Penalva3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Anh D Le$4,956,118
- Aaron Samuel Meyer$4,629,249
- Paul S Mischel$15,265,453
- Koki Morizono$5,593,709
- Utpal Banerjee$21,280,716
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsGrowthGlioblastomaTumorStem CellsGliomaSignal TransductionResistanceMalignant Neoplasm Of BrainAffectMolecularBaseOncogenicNeoplastic CellTumorigenicInhibitor/AntagonistTranslationsRadiation TherapyTherapy ResistantCell SurvivalRadiationBrainMediating
Grant awards (37)
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers$447,102
R01 · FY2022 · CA
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers$456,227
R01 · FY2021 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease$465,676
R01 · FY2020 · CA
Brain tumor recurrence via signals from vascular endothelial cells$385,704
R01 · FY2020 · NS · contact PI
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers$316,864
R01 · FY2020 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease$451,697
R01 · FY2019 · CA
Radiation-Induced Crosstalk of Immune and Glioma Stem Cells$320,209
R01 · FY2019 · NS · contact PI
Novel role of compensatory proliferation in human brain tumor$306,984
R01 · FY2019 · CA · contact PI
The roles of a unique GTP-binding protein/crosslinking enzyme in disease$465,660
R01 · FY2018 · CA
Metabolism Informs Intertumoral & Intratumoral Heterogeneity$386,856
R01 · FY2018 · NS
Novel role of compensatory proliferation in human brain tumor$317,924
R01 · FY2018 · CA · contact PI
The roles of a unique GTP-binding protein/crosslinking enzyme in disease$465,651
R01 · FY2017 · CA
Novel role of compensatory proliferation in human brain tumor$319,325
R01 · FY2017 · CA · contact PI
Targeting MELK-mediated EZH2 signaling in glioma stem cells$277,376
R01 · FY2017 · NS · contact PI
Metabolism Informs Intertumoral & Intratumoral Heterogeneity$275,251
R01 · FY2017 · NS
Malignant Gliomas Biorepository Core$142,311
P01 · FY2017 · CA · contact PI
Metabolism Informs Intertumoral & Intratumoral Heterogeneity$121,716
R01 · FY2017 · NS
Metabolism Informs Intertumoral & Intratumoral Heterogeneity$402,301
R01 · FY2016 · NS
The roles of a unique GTP-binding protein/crosslinking enzyme in disease$400,259
R01 · FY2016 · CA
Novel role of compensatory proliferation in human brain tumor$332,436
R01 · FY2016 · CA · contact PI
Targeting MELK-mediated EZH2 signaling in glioma stem cells$289,126
R01 · FY2016 · NS · contact PI
Malignant Gliomas Biorepository Core$140,569
P01 · FY2016 · CA · contact PI
Metabolism Informs Intertumoral & Intratumoral Heterogeneity$407,147
R01 · FY2015 · NS
Novel role of compensatory proliferation in human brain tumor$350,712
R01 · FY2015 · CA · contact PI
Targeting MELK-mediated EZH2 signaling in glioma stem cells$185,033
R01 · FY2015 · NS · contact PI
Malignant Gliomas Biorepository Core$136,565
P01 · FY2015 · CA · contact PI
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells$100,748
R21 · FY2015 · CA · contact PI
Targeting MELK-mediated EZH2 signaling in glioma stem cells$70,084
R01 · FY2015 · NS · contact PI
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells$64,378
R21 · FY2015 · CA · contact PI
Metabolism Informs Intertumoral & Intratumoral Heterogeneity$426,906
R01 · FY2014 · NS
Targeting MELK-mediated EZH2 signaling in glioma stem cells$252,565
R01 · FY2014 · NS · contact PI
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells$211,494
R21 · FY2014 · CA · contact PI
Malignant Gliomas Biorepository Core$133,615
P01 · FY2014 · CA · contact PI
Targeting MELK-mediated EZH2 signaling in glioma stem cells$268,082
R01 · FY2013 · NS · contact PI
Malignant Gliomas Biorepository Core$148,663
P01 · FY2013 · CA · contact PI
Characterization of CD44 in brain tumor stem cells$167,750
R21 · FY2010 · CA · contact PI
Characterization of CD44 in brain tumor stem cells$203,280
R21 · FY2009 · CA · contact PI